Allarity Therapeutics, Inc. Convertible Preferred Stock Converted to Other Securities
Allarity Therapeutics, Inc. (ALLR) reported Convertible Preferred Stock Converted to Other Securities of $812.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities · last filed 2023-11-14
- Allarity Therapeutics, Inc. convertible preferred stock converted to other securities for the quarter ending 2023-06-30 was $812.00K.
- Allarity Therapeutics, Inc. convertible preferred stock converted to other securities for the quarter ending 2023-03-31 was $565.00K.
- Allarity Therapeutics, Inc. convertible preferred stock converted to other securities for the quarter ending 2022-12-31 was -$557.00K.
- Allarity Therapeutics, Inc. convertible preferred stock converted to other securities for fiscal 2022 was $954.00K.
| Period end | Convertible Preferred Stock Converted to Other Securities 1 month | Convertible Preferred Stock Converted to Other Securities 3 month | Convertible Preferred Stock Converted to Other Securities 6 month | Convertible Preferred Stock Converted to Other Securities 9 month | Convertible Preferred Stock Converted to Other Securities 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $812.00K 10-Q · filed 2023-11-14 | $1.38M derived: sum of 2 quarters · filed 2023-11-14 | $820.00K derived: sum of 3 quarters · filed 2023-11-14 | ||
| 2023-03-31 | $565.00K 10-Q · filed 2023-11-14 | $8.00K derived: sum of 2 quarters · filed 2023-11-14 | |||
| 2022-12-31 | -$557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $954.00K 10-K · filed 2023-03-13 | |||
| 2022-09-30 | $1.51M 10-Q · filed 2023-11-14 | ||||
| 2022-03-31 | $1.57K 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |